Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer. - Wikidata - awgldk - TriplyDB

Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.

Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.

http://www.wikidata.org/entity/Q30459302

about

Prospects for Improving Brain Function in Individuals with Down Syndrome Timing of therapies for Down syndrome: the sooner, the better Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome Sheltering behavior and locomotor activity in 11 genetically diverse common inbred mouse strains using home-cage monitoring Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations.Behavioral abnormalities and circuit defects in the basal ganglia of a mouse model of 16p11.2 deletion syndrome.β1-adrenergic receptor activation enhances memory in Alzheimer's disease model Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.Chronic up-regulation of the SHH pathway normalizes some developmental effects of trisomy in Ts65Dn mice.Age-related neurodegeneration and memory loss in down syndrome.From abnormal hippocampal synaptic plasticity in down syndrome mouse models to cognitive disability in down syndrome.Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists.Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models.The need for speed in rodent locomotion analyses.An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome.Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome.Weaker control of the electrical properties of cerebellar granule cells by tonically active GABAA receptors in the Ts65Dn mouse model of Down's syndrome.Increased Sparsity of Hippocampal CA1 Neuronal Ensembles in a Mouse Model of Down Syndrome Assayed by Arc Expression.Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.Neuromodulatory signaling in hippocampus-dependent memory retrieval.Xamoterol impairs hippocampus-dependent emotional memory retrieval via Gi/o-coupled β2-adrenergic signaling.Update of neurotrophic factors in neurobiology of addiction and future directions.Improving Memory and Cognition in Individuals with Down Syndrome.Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.Dentate gyrus mediates cognitive function in the Ts65Dn/DnJ mouse model of Down syndrome.GABAergic hyperinnervation of dentate granule cells in the Ts65Dn mouse model of down syndrome: Exploring the role of App.Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders.Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome.Rodent models in Down syndrome research: impact and future opportunities.Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities.Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice.Adaptation of the Arizona Cognitive Task Battery for use with the Ts65Dn mouse model (Mus musculus) of Down syndrome.Does ceruloplasmin differential express in the brain of Ts65Dn: a mouse mode of Down syndrome?

P2860

Q22252566-EDD9F89E-4DB1-4E72-BFE1-BE48227F57B8 Q26779297-A3640A82-928F-4BA2-8213-F3626D2A8011 Q27300997-92B84141-22D5-46CA-A71A-696235FA0577 Q28542515-F0C0E2C1-003D-411E-AA0B-A5E055AA2218 Q28543368-219B149C-C530-42C2-B998-89C4E82A97EF Q30422188-5C99C156-B943-47D6-A729-3E59C951E0BD Q30423739-E4AE40EE-F941-4751-A660-E3ABE57A83A4 Q33678421-3BDDE85E-F5E8-4B7E-B5B5-36B0BBFF0251 Q34454393-7FCE2D56-74CF-4AE7-8289-98B52CAB9139 Q34980227-9BBC2E84-A444-46B2-8225-4BD2CDEB2F5C Q35867093-97AA97C3-6A75-4A00-8742-614DF3421172 Q36111747-14CEC9B8-4440-494F-8993-ADC4C2E39C68 Q36138353-65FE2613-F044-4923-9045-FD1B828B937D Q36177608-4B8ABD31-3F0B-41F4-AB54-798188CB80BB Q36592396-8E3B6928-F5E3-4EEC-A534-F25995AA9CE9 Q36739111-92DF18A5-0C01-4270-9D52-61A1A73BE4AC Q36965872-FDD42A84-DAEB-48EC-9B77-E2D5933D89FD Q37045414-E48FCF00-DCFD-4077-8FA4-8F2900A1B922 Q37622021-E30D1CD9-8D9F-4999-AC01-0C1BCAFFEA9C Q37734742-255875E6-DC6A-436D-A05B-4B8C56EC9721 Q38283275-D69347A2-F97F-499C-A22E-E892E360F1FB Q38302843-50EB277E-4803-485F-9623-8DF4C67D7A86 Q38770267-121060F5-A635-4AB0-BD75-2C6D813E0E37 Q38858096-D3A0D2BD-05BB-4530-B533-9011C20DB1A2 Q39019439-C9FE4114-C9E3-4E87-9289-26BCD869CD91 Q39294662-9A6ADC7E-5090-4F7A-91A3-6B366887325A Q39324113-D32B8B2B-37BC-4A34-981E-D50F57F73EB5 Q41137764-258418FC-1930-43E2-AAE9-9CCBB3D135C8 Q41184300-04C67140-09C9-42BE-BBC8-EF5CEA099597 Q42486904-EE23FF1C-E433-44DB-B6EF-D6D4814EB963 Q46193918-2E25AAD4-D9F3-403C-8759-557D936E49C1 Q46652242-77DA38E0-2F26-45C1-A707-D5E9636CBC95 Q47745776-CBA90C64-C595-4CC1-9B88-6A6EE1009B12 Q48031560-90659787-3A4C-426A-B880-A571153B02DE Q48370031-D52B0A78-F5F8-444E-8DE1-B4CB9A01B14D Q48867998-773363CC-5329-4E31-B17D-0B0D1302E314

P2860

Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.

http://www.wikidata.org/entity/Q30459302

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Comprehensive behavioral pheno ...... potential cognitive enhancer.

@ast

Comprehensive behavioral pheno ...... potential cognitive enhancer.

@en

type

label

Comprehensive behavioral pheno ...... potential cognitive enhancer.

@ast

Comprehensive behavioral pheno ...... potential cognitive enhancer.

@en

prefLabel

Comprehensive behavioral pheno ...... potential cognitive enhancer.

@ast

Comprehensive behavioral pheno ...... potential cognitive enhancer.

@en

P1433

Q30459302-8D8E5D9D-677E-4112-BC66-22B65C759788

P1476

Q30459302-10713958-C176-4E01-9F9A-51E329C3932E

P2093

Q30459302-15F0E958-92EB-4D51-827A-92FFF4828EF9

Q30459302-198E40DB-52DC-4465-BFC0-0D5202291329

Q30459302-2A2312F9-AB47-453F-B169-3DFD5A44B65E

Q30459302-435C54C5-EF86-4497-A5C3-2E2E514AE720

Q30459302-59389C6C-2D55-4921-BCDB-D69FA6CD9EC9

Q30459302-7C9B510A-E729-4EA4-9A5E-84466E07A5B8

Q30459302-837D173E-C859-47BC-B154-EAEFCE2265F1

Q30459302-AD5C3B32-282D-45C9-87BB-7E703C0490CD

Q30459302-CC0B895B-AC6A-4D5F-B977-5446B3DC818B

Q30459302-DDEC9274-E562-41C6-B375-C762801D9F89

P2860

Q30459302-05A992F8-EEF8-489A-87AC-B0D8DD27D655

Q30459302-0C06479C-13B1-40DB-BECF-0FDDAF8A4469

Q30459302-10C1B8FF-DFDD-4716-88C8-7276F9F10052

Q30459302-16E510D4-83C6-4D81-A9DB-3E882023340E

Q30459302-17B833FC-577B-412A-B83F-B43E496D315E

Q30459302-19A4FB8E-5718-49AB-9C23-E64338EAD448

Q30459302-1A9A9C8D-0B21-4577-9A0A-7EF0D88C68E8

Q30459302-1BC98292-31AF-4FCB-83F0-6413745E01DA

Q30459302-1DE84694-5BCC-46C8-A83B-DD4577160AD2

Q30459302-1F09DFF2-A463-49B1-AC89-C51A861012BF

P304

Q30459302-CBE201DB-5247-40EA-98B7-110FD8F826A7

P31

Q30459302-10E2A2C2-919F-4F37-8E73-6B42DADFD567

P356

Q30459302-30D01F87-6C3F-4384-8BCB-AEE0E337A783

P433

Q30459302-9B58477F-3901-49AB-8231-98DBFB251AB0

P478

Q30459302-EF5AAD28-B901-41EE-8C30-96B6992E71C4

P577

Q30459302-8B013390-5012-4631-A167-EB07276EC4E8

P698

Q30459302-655C608B-CC0D-498A-9911-C8FB73833CBE

P932

Q30459302-DF8A10F8-71BB-45BD-B9AB-3F9CA7811980

P356

J.NBD.2011.04.011

P1433

Neurobiology of Disease

P1476

Comprehensive behavioral pheno ...... potential cognitive enhancer.

@en

P2093

Alexander Kleschevnikov

http://www.w3.org/2001/XMLSchema#string

Angelo Encarnacion

http://www.w3.org/2001/XMLSchema#string

Christine Tun

http://www.w3.org/2001/XMLSchema#string

Matthew Priestley

http://www.w3.org/2001/XMLSchema#string

Mehrdad Faizi

http://www.w3.org/2001/XMLSchema#string

Mehrdad Shamloo

http://www.w3.org/2001/XMLSchema#string

Nay Saw

http://www.w3.org/2001/XMLSchema#string

Patrick L Bader

http://www.w3.org/2001/XMLSchema#string

Pavel Belichenko

http://www.w3.org/2001/XMLSchema#string

Richard W Tsien

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of dentate granule cell destruction on behavioural activity and Fos protein expression induced by systemic methamphetamine in rats

A distinct role for norepinephrine in memory retrieval

Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice

Modality-specific retrograde amnesia of fear

Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains

Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus.

Differential involvement of the central amygdala in appetitive versus aversive learning.

A comparison of wild-caught wood mice and bank voles in the Intellicage: assessing exploration, daily activity patterns and place learning paradigms.

Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.

Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome.

P304

397-413

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NBD.2011.04.011

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21527343

http://www.w3.org/2001/XMLSchema#string

P932

3539757

http://www.w3.org/2001/XMLSchema#string